Jerome Schaufeld

Director/Board Member at

Medvance Solutions, Inc.

Finance

Technology Services

Profile

Mr. Schaufeld was formerly Executive Vice President of the Slater Fund, Rhode Island's state venture fund.
Previously, he served as the President and CEO of Mass Ventures, a western Massachusetts venture development company, and he was the founder of Incus Group, a CEO-based business acquisition organization.
He also was co-founder of Phoenix Controls Corporation which pioneered the manufacturing of air flow systems in critical laboratory and hospital environments.
Phoenix was recently sold to a Fortune 500 company.
Prior to that, he held senior functional responsibilities at a series of technology-based manufacturing companies.
Mr. Schaufeld was founder and first Chairman of the MIT Enterprise Forum in Cambridge, Massachusetts and serves on numerous boards of technology-based companies and several non-profit organizations, including the National Association of Corporate Directors and the Association for Corporate Growth.
Mr. Schaufeld has a BSME from New Jersey Institute of Technology, an MBA from Northeastern and attended MIT Sloan School of Management.

Jerome Schaufeld active positions

Companies	Position	Start
Medvance Solutions, Inc. Medvance Solutions, Inc. Packaged SoftwareTechnology Services Provides medical communications solutions to patients	Director/Board Member	-

All active positions of Jerome Schaufeld

Former positions of Jerome Schaufeld

Companies	Position	End
Navigator Technology Ventures LLC Navigator Technology Ventures LLC Investment ManagersFinance Navigator invest in start ups with the following profile: early and later-stage, technology rich startups with strong proprietary position built around a core technology, a prototype or proof-of-concept, co-invest in follow-on rounds with other VCs and focused in New England. The firm leads or co-leads the first round of investment. They take an active role and board seat in embryonic companies. They seek innovative technological ideas. Although Navigator does not limit themselves to any particular technology domain, their main areas of concentration are electronics, wireless, information technology and biotechnology.	Private Equity Investor	2008-12-30
Mass Ventures Corp. Mass Ventures Corp. Investment ManagersFinance Mass Ventures Corp. manages the Mass Ventures Equity Fund LP. The fund is an early-stage fund targeted at Western Massachusetts. The firm focuses on a number of different industries, but primarily invests in smaller niche markets	President	-

See the detail of Jerome Schaufeld's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Jerome Schaufeld's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	3
Medvance Solutions, Inc. Medvance Solutions, Inc. Packaged SoftwareTechnology Services Provides medical communications solutions to patients	Technology Services
Mass Ventures Corp. Mass Ventures Corp. Investment ManagersFinance Mass Ventures Corp. manages the Mass Ventures Equity Fund LP. The fund is an early-stage fund targeted at Western Massachusetts. The firm focuses on a number of different industries, but primarily invests in smaller niche markets	Finance
Navigator Technology Ventures LLC Navigator Technology Ventures LLC Investment ManagersFinance Navigator invest in start ups with the following profile: early and later-stage, technology rich startups with strong proprietary position built around a core technology, a prototype or proof-of-concept, co-invest in follow-on rounds with other VCs and focused in New England. The firm leads or co-leads the first round of investment. They take an active role and board seat in embryonic companies. They seek innovative technological ideas. Although Navigator does not limit themselves to any particular technology domain, their main areas of concentration are electronics, wireless, information technology and biotechnology.	Finance